{"entity":{"type":"insider","cik":"0001769674","url":"/insider/0001769674","json_url":"/insider/0001769674.json","name":"Economides Vassiliki","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2019-07-23","last":"2024-12-20","span_basis":"filed_date"},"name_variants":[{"name":"Economides Vassiliki","source":"filing","n_filings":8,"first_seen":"2019-07-23","last_seen":"2024-12-20"}],"transactions":[{"id":2191437,"accession":"0001415889-24-029968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-029968","line_url":"/filing/0001415889-24-029968#line-1","is_derivative":false,"issuer_cik":"0001656634","issuer_name":"Gritstone bio, Inc.","issuer_ticker":"GRTS","issuer_name_source":null,"issuer_url":"/issuer/0001656634","owner_cik":"0001769674","owner_name":"Economides Vassiliki","owner_display_name":"Economides Vassiliki","owner_url":"/insider/0001769674","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":0.015,"price_display":"0.02","price_state":"stated","total_value":180.0,"total_display":"180.00","total_whole":"180","shares_owned_after":250437.0,"shares_owned_after_display":"250,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-20","scope":"insider"},{"id":2256284,"accession":"0001415889-24-013653","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-013653","line_url":"/filing/0001415889-24-013653#line-2","is_derivative":false,"issuer_cik":"0001656634","issuer_name":"Gritstone bio, Inc.","issuer_ticker":"GRTS","issuer_name_source":null,"issuer_url":"/issuer/0001656634","owner_cik":"0001769674","owner_name":"Economides Vassiliki","owner_display_name":"Economides Vassiliki","owner_url":"/insider/0001769674","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13749.0,"shares_display":"13,749","price_per_share":0.7483,"price_display":"0.75","price_state":"stated","total_value":10288.3767,"total_display":"10,288.38","total_whole":"10,288","shares_owned_after":262437.0,"shares_owned_after_display":"262,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider"},{"id":7834404,"accession":"0000899243-23-013810","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-013810","line_url":"/filing/0000899243-23-013810#line-1","is_derivative":false,"issuer_cik":"0001656634","issuer_name":"Gritstone bio, Inc.","issuer_ticker":"GRTS","issuer_name_source":null,"issuer_url":"/issuer/0001656634","owner_cik":"0001769674","owner_name":"Economides Vassiliki","owner_display_name":"Economides Vassiliki","owner_url":"/insider/0001769674","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.9024,"price_display":"1.90","price_state":"stated","total_value":22828.8,"total_display":"22,828.80","total_whole":"22,829","shares_owned_after":214058.0,"shares_owned_after_display":"214,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider"},{"id":3253713,"accession":"0001209191-20-007054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-007054","line_url":"/filing/0001209191-20-007054#line-1","is_derivative":false,"issuer_cik":"0001645666","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001645666","owner_cik":"0001769674","owner_name":"Economides Vassiliki","owner_display_name":"Economides Vassiliki","owner_url":"/insider/0001769674","role":"Officer (SVP, Strategy & External Aff)","role_mark":"O","role_mark_label":"Officer (SVP, Strategy & External Aff)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Strategy & External Aff.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5769.0,"shares_display":"5,769","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":14999.4,"total_display":"14,999.40","total_whole":"14,999","shares_owned_after":7570.0,"shares_owned_after_display":"7,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-05","scope":"insider"},{"id":8395888,"accession":"0001209191-19-047055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-047055","line_url":"/filing/0001209191-19-047055#line-1","is_derivative":false,"issuer_cik":"0001645666","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001645666","owner_cik":"0001769674","owner_name":"Economides Vassiliki","owner_display_name":"Economides Vassiliki","owner_url":"/insider/0001769674","role":"Officer (SVP, Strategy & External Aff)","role_mark":"O","role_mark_label":"Officer (SVP, Strategy & External Aff)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Strategy & External Aff.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350.0,"shares_display":"350","price_per_share":4.4102,"price_display":"4.41","price_state":"stated","total_value":1543.57,"total_display":"1,543.57","total_whole":"1,544","shares_owned_after":1801.0,"shares_owned_after_display":"1,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":8619128,"accession":"0001209191-19-045644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-045644","line_url":"/filing/0001209191-19-045644#line-1","is_derivative":false,"issuer_cik":"0001645666","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001645666","owner_cik":"0001769674","owner_name":"Economides Vassiliki","owner_display_name":"Economides Vassiliki","owner_url":"/insider/0001769674","role":"Officer (SVP, Strategy & External Aff)","role_mark":"O","role_mark_label":"Officer (SVP, Strategy & External Aff)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Strategy & External Aff.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1020.0,"shares_display":"1,020","price_per_share":4.9582,"price_display":"4.96","price_state":"stated","total_value":5057.364,"total_display":"5,057.36","total_whole":"5,057","shares_owned_after":1451.0,"shares_owned_after_display":"1,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":8120129,"accession":"0001209191-19-042975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-042975","line_url":"/filing/0001209191-19-042975#line-1","is_derivative":false,"issuer_cik":"0001645666","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001645666","owner_cik":"0001769674","owner_name":"Economides Vassiliki","owner_display_name":"Economides Vassiliki","owner_url":"/insider/0001769674","role":"Officer (SVP, Strategy & External Aff)","role_mark":"O","role_mark_label":"Officer (SVP, Strategy & External Aff)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Strategy & External Aff.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":431.0,"shares_display":"431","price_per_share":5.8207,"price_display":"5.82","price_state":"stated","total_value":2508.7217,"total_display":"2,508.72","total_whole":"2,509","shares_owned_after":431.0,"shares_owned_after_display":"431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-07-23","scope":"insider"},{"id":4331090,"accession":"0001209191-21-023464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-023464","line_url":"/filing/0001209191-21-023464#line-1","is_derivative":false,"issuer_cik":"0001645666","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001645666","owner_cik":"0001769674","owner_name":"Economides Vassiliki","owner_display_name":"Economides Vassiliki","owner_url":"/insider/0001769674","role":"Officer (SVP, Strategy & External Aff)","role_mark":"O","role_mark_label":"Officer (SVP, Strategy & External Aff)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Strategy & External Aff.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":10.19,"price_display":"10.19","price_state":"stated","total_value":7642.5,"total_display":"7,642.50","total_whole":"7,643","shares_owned_after":11320.0,"shares_owned_after_display":"11,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2021-03-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001656634","name":"Gritstone bio, Inc.","url":"/issuer/0001656634","role":"Officer (EVP, CHIEF FINANCIAL OFFICER)","n_filings":3,"first_seen":"2023-05-24","last_seen":"2024-12-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001645666","name":"Kezar Life Sciences, Inc.","url":"/issuer/0001645666","role":"Officer (SVP, Strategy & External Aff)","n_filings":5,"first_seen":"2019-07-23","last_seen":"2021-03-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001769674","retrieved_at":"2026-08-25T08:58:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}